Institution profile

Parexel

Industry researchnorthamerica · us
Official website
Research library3linked papers
Opportunities0open roles
Selected work

Representative Papers

Regulatory Considerations for Using Artificial Intelligence Models to Reduce Sample Sizes in Registrational Studies

May 22, 2026

This study addresses the challenge of safely and effectively reducing sample sizes in registered clinical trials while adhering to regulatory requirements. Building upon the FDA’s seven-step risk assessment framework, the work presents the first systematic application of AI model trustworthiness evaluation guidelines to the context of sample size reduction. By constructing prognostic covariates, conducting risk-informed model development and validation, and integrating these with statistical re-estimation methods, the approach recalculates the required trial sample size. Demonstrated in a randomized controlled trial for Alzheimer’s disease, the methodology enabled prospective sample size reduction, substantially shortening trial duration, lowering costs, and accelerating the availability of effective therapies. This provides a generalizable, AI-driven framework for enhancing the efficiency of drug development.

0 citationsRead paper

Retrieval or Representation? Reassessing Benchmark Gaps in Multilingual and Visually Rich RAG

Mar 04, 2026

This study addresses a critical limitation in existing retrieval-augmented generation (RAG) benchmarks: their inability to disentangle performance gains stemming from improvements in retrieval mechanisms versus those arising from enhanced document representations. To isolate the impact of document preprocessing, the authors fix the retriever—using BM25 as a consistent baseline—and systematically evaluate diverse document transcription and preprocessing strategies across multilingual and visually dense RAG tasks. Their experiments reveal that optimizing document representation alone substantially narrows the performance gap between BM25 and state-of-the-art multimodal retrievers, indicating that much of the observed gain in current systems originates from representation quality rather than retrieval algorithmic advances. Based on these findings, the work advocates for a new benchmarking paradigm that decouples document transcription from retrieval capability to enable more precise evaluation of RAG components.

0 citationsRead paper
Recent publications

Latest Papers

Regulatory Considerations for Using Artificial Intelligence Models to Reduce Sample Sizes in Registrational Studies

May 22, 2026

This study addresses the challenge of safely and effectively reducing sample sizes in registered clinical trials while adhering to regulatory requirements. Building upon the FDA’s seven-step risk assessment framework, the work presents the first systematic application of AI model trustworthiness evaluation guidelines to the context of sample size reduction. By constructing prognostic covariates, conducting risk-informed model development and validation, and integrating these with statistical re-estimation methods, the approach recalculates the required trial sample size. Demonstrated in a randomized controlled trial for Alzheimer’s disease, the methodology enabled prospective sample size reduction, substantially shortening trial duration, lowering costs, and accelerating the availability of effective therapies. This provides a generalizable, AI-driven framework for enhancing the efficiency of drug development.

0 citationsRead paper

Retrieval or Representation? Reassessing Benchmark Gaps in Multilingual and Visually Rich RAG

Mar 04, 2026

This study addresses a critical limitation in existing retrieval-augmented generation (RAG) benchmarks: their inability to disentangle performance gains stemming from improvements in retrieval mechanisms versus those arising from enhanced document representations. To isolate the impact of document preprocessing, the authors fix the retriever—using BM25 as a consistent baseline—and systematically evaluate diverse document transcription and preprocessing strategies across multilingual and visually dense RAG tasks. Their experiments reveal that optimizing document representation alone substantially narrows the performance gap between BM25 and state-of-the-art multimodal retrievers, indicating that much of the observed gain in current systems originates from representation quality rather than retrieval algorithmic advances. Based on these findings, the work advocates for a new benchmarking paradigm that decouples document transcription from retrieval capability to enable more precise evaluation of RAG components.

0 citationsRead paper